Krebs Biochemicals Hits Upper Circuit Limit Amidst Strong Trading Activity and Sector Outperformance
2025-04-03 10:00:08Krebs Biochemicals & Industries Ltd, a microcap player in the Pharmaceuticals & Drugs sector, has shown significant activity today, hitting its upper circuit limit. The stock reached an intraday high of Rs 74.5, reflecting a notable increase of 4.86% during the trading session. The last traded price stands at Rs 71.05, marking an absolute change of 3.38 and a percentage change of 4.99%. The stock has been on a positive trajectory, gaining for three consecutive days and achieving a total return of 12.1% over this period. Today's performance outpaced the sector, which saw a gain of 3.59%. Despite a decline in delivery volume, which fell by 83.79% compared to the five-day average, the stock remains liquid enough for trading activities. With a market capitalization of Rs 160.41 crore, Krebs Biochemicals & Industries continues to navigate the competitive landscape of the pharmaceuticals sector. Overall, the st...
Read MoreKrebs Biochemicals Hits Upper Circuit Limit Amid Declining Investor Participation
2025-04-02 10:00:05Krebs Biochemicals & Industries Ltd, a microcap player in the Pharmaceuticals & Drugs sector, has shown significant activity today as its stock hit the upper circuit limit. The stock reached a high price of Rs 69.68, reflecting a change of Rs 1.23, or an increase of 1.85%. The last traded price was Rs 67.6, with a low of Rs 66.5 during the trading session. The total traded volume stood at 0.0131 lakh shares, resulting in a turnover of approximately Rs 0.00896 crore. Despite today's positive movement, the stock is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a trend of lower performance over these periods. Additionally, investor participation has seen a decline, with delivery volume dropping by 91.78% compared to the 5-day average. In summary, Krebs Biochemicals & Industries Ltd's stock performance today highlights a notable upward movement, reaching i...
Read MoreKrebs Biochemicals Shows Resilience Amidst Broader Market Declines and Increased Investor Interest
2025-04-01 12:00:04Krebs Biochemicals & Industries Ltd, a microcap player in the Pharmaceuticals & Drugs sector, has shown significant activity today as it hit its upper circuit limit. The stock reached a high price of 69.68, reflecting a change of 0.35, or an increase of 0.53%. The last traded price (LTP) was recorded at 66.72, with a low of 66.5 during the trading session. The stock's performance today outpaced its sector by 1.6%, indicating a positive trend amidst broader market challenges, as the sector and Sensex reported declines of 1.43% and 1.30%, respectively. Total traded volume stood at 0.00805 lakh, with a turnover of 0.005511835 crore. Notably, the delivery volume on March 28 saw a rise of 30.67% compared to the five-day average, suggesting increased investor participation. Despite trading below its moving averages across various time frames, Krebs Biochemicals has demonstrated resilience in today's market. Ove...
Read MoreKrebs Biochemicals Faces Continued Decline Amid Weak Market Sentiment and Trading Activity
2025-03-28 15:00:04Krebs Biochemicals & Industries Ltd, a microcap player in the Pharmaceuticals & Drugs sector, has experienced significant trading activity today, hitting its lower circuit limit. The stock closed at Rs 67.83, reflecting a decline of Rs 1.78 or 2.56% from the previous session. The stock's performance has been notably weak, underperforming its sector by 3.01% and marking a consecutive fall over the last six days, resulting in a total decline of 12.96% during this period. During today's trading, Krebs Biochemicals reached an intraday high of Rs 71.00 but fell to a low of Rs 66.12, which represents a decrease of 5.01%. The total traded volume was approximately 0.11883 lakh shares, with a turnover of Rs 0.079996356 crore. The weighted average price indicates that more volume was traded closer to the low price, suggesting a lack of upward momentum. Additionally, the stock is currently trading below its 5-day, 2...
Read MoreKrebs Biochemicals Faces Intense Selling Pressure Amid Significant Price Declines
2025-03-28 14:25:04Krebs Biochemicals & Industries Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has experienced a notable decline, with its stock price down 3.00% in a single day, compared to a modest 0.26% drop in the Sensex. Over the past week, Krebs Biochemicals has lost 12.47%, while the Sensex has gained 0.65%. This trend continues over a month, with the stock down 16.82% against a 5.75% increase in the Sensex. The stock has been on a downward trajectory for three consecutive days, accumulating a total loss of 10.87% during this period. It opened with a gap down of 4.28% today and reached an intraday low of Rs 66.78, reflecting a decline of 4.74%. Furthermore, Krebs Biochemicals is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a persistent bearish trend. Potential contributing factors to this selling pressure may...
Read MoreKrebs Biochemicals Experiences Significant Volatility Amid Declining Investor Participation
2025-03-25 10:00:06Krebs Biochemicals & Industries Ltd, a microcap player in the Pharmaceuticals & Drugs sector, has made headlines today as its stock hit the upper circuit limit, reaching a high price of 78.33. Despite a last traded price of 74.00, the stock's performance reflects notable volatility, with a change of -0.6 and a percentage change of -0.8. The stock traded within a price band of 5%, with an intraday low of 73.46. Total traded volume was recorded at 0.0028 lakhs, resulting in a turnover of 0.002093 crore. The stock's performance today underperformed the sector by 0.7%, and it is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Investor participation appears to be declining, with delivery volume dropping by 12% compared to the 5-day average. The liquidity of the stock remains adequate for trading, based on 2% of the 5-day average traded value. In summary, Krebs Bioche...
Read MoreKrebs Biochemicals Sees Surge in Trading Activity Amid Sector Outperformance
2025-03-19 15:00:04Krebs Biochemicals & Industries Ltd, a microcap player in the Pharmaceuticals & Drugs sector, has experienced significant trading activity today, hitting its upper circuit limit with a high price of Rs 75.71. The stock recorded a notable change of Rs 3.39, reflecting a percentage increase of 4.7%. Throughout the trading session, the stock fluctuated between a low of Rs 69.00 and the aforementioned high, showcasing a price band of 5%. Total traded volume reached approximately 0.01199 lakh shares, contributing to a turnover of Rs 0.008949336 crore. In terms of performance metrics, Krebs Biochemicals has outperformed its sector by 3.89% today, marking a trend reversal after three consecutive days of decline. However, it is important to note that the stock is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, there has been a rise in investor participati...
Read MoreKrebs Biochemicals Faces Intense Selling Pressure Amid Significant Price Declines
2025-03-10 15:35:04Krebs Biochemicals & Industries Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The stock has experienced consecutive days of losses, reflecting a troubling trend for investors. Today, Krebs Biochemicals reported a decline of 5.00%, significantly underperforming the Sensex, which fell by just 0.29%. Over the past week, the stock has decreased by 1.40%, while the Sensex gained 1.41%. In the last month, Krebs Biochemicals has seen a steep decline of 17.85%, compared to a 4.13% drop in the Sensex. The three-month performance reveals a 25.23% decrease for Krebs, against a 9.07% decline in the Sensex. Year-to-date, the stock is down 12.70%, while the Sensex has decreased by 5.15%. The stock opened with a gap down of 3.53% today and reached an intraday low of Rs 80.75. Notably, it has underperformed its sector by 4.22%. The erratic trading pattern, with the sto...
Read MoreKrebs Biochemicals Faces Increased Volatility Amid Significant Trading Activity Decline
2025-03-10 15:00:04Krebs Biochemicals & Industries Ltd, a microcap player in the Pharmaceuticals & Drugs sector, experienced significant trading activity today, hitting its lower circuit limit. The stock closed at Rs 81.46, reflecting a decline of 5.0% or an absolute change of Rs 4.29. This downturn marks a reversal after three consecutive days of gains. The stock reached an intraday low of Rs 81.46, with a high of Rs 86.0, indicating a notable volatility of 5.47% throughout the trading session. Total traded volume was recorded at 0.0414 lakh shares, resulting in a turnover of approximately Rs 0.03377 crore. The performance today underperformed the sector by 3.98%, with the stock's 1D return at -5.00%, compared to a sector return of -1.02% and a Sensex return of -0.45%. Additionally, the stock's delivery volume has seen a significant decline, falling by 72.59% against the five-day average. Despite trading above its five-day...
Read MoreCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
02-Apr-2025 | Source : BSEThe Company has enclosed herewith compliances certificate under Reg. 74 (5) of SEBI DP Regulations 2018 for the quarter ended 31.03.2025
Shareholder Meeting / Postal Ballot-Scrutinizers Report
31-Mar-2025 | Source : BSEThe Company has enclosed herewith voting results under reg 44 along with scrutinizer Report for the postal ballot notice dated 4th February 2025
Announcement under Regulation 30 (LODR)-Cessation
24-Mar-2025 | Source : BSEThe Company has enclosed herewith intimation for completion of tenure of Mr. Satish Khivsara as an Independent Director
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
Krebs Biochemicals & Industries Ltd has announced 21:100 rights issue, ex-date: 31 Jan 19